Evidence map›Paper›PMID 33303540›Full record

ArticleThe European respiratory journal2021

Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19.

Tøri Vigeland Lerum, Trond Mogens Aaløkken, Eivind Brønstad, Bernt Aarli, Eirik Ikdahl, Kristine Marie Aarberg Lund, Michael T Durheim, Jezabel Rivero Rodriguez, Carin Meltzer, Kristian Tonby and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The European respiratory journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 205 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed, 15 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

205 citing papers in PubMed, 15 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  5. SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  6. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2022
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. ESCMID rapid guidelines for assessment and management of long COVID.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Guideline
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID.Respiration; international review of thoracic diseases · 2021
    Guideline
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Tøri Vigeland LerumDept of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Trond Mogens AaløkkenDept of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Eivind BrønstadThoracic Dept, St Olavs Hospital, Trondheim, Norway.
Bernt AarliDept of Thoracic Medicine, Haukeland University Hospital, Haukeland, Norway.
Eirik IkdahlPulmonary Dept, Akershus University Hospital, Lørenskog, Norway.
Kristine Marie Aarberg LundDept of Infectious Diseases, Østfold Hospital Trust Kalnes, Grålum, Norway.
Michael T DurheimInstitute for Clinical Medicine, University of Oslo, Oslo, Norway.
Jezabel Rivero RodriguezDept of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Carin MeltzerDept of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Kristian TonbyInstitute for Clinical Medicine, University of Oslo, Oslo, Norway.
Knut StavemInstitute for Clinical Medicine, University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0003-4512-8000
Ole Henning SkjønsbergDept of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Haseem AshrafInstitute for Clinical Medicine, University of Oslo, Oslo, Norway.
Gunnar EinvikInstitute for Clinical Medicine, University of Oslo, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The long-term pulmonary outcomes of coronavirus disease 2019 (COVID-19) are unknown. We aimed to describe self-reported dyspnoea, quality of life, pulmonary function and chest computed tomography (CT) findings 3 months following hospital admission for COVID-19. We hypothesised outcomes to be inferior for patients admitted to intensive care units (ICUs), compared with non-ICU patients.Discharged COVID-19 patients from six Norwegian hospitals were enrolled consecutively in a prospective cohort study. The current report describes the first 103 participants, including 15 ICU patients. The modified Medical Research Council (mMRC) dyspnoea scale, the EuroQol Group's questionnaire, spirometry, diffusing capacity of the lung for carbon monoxide (

Indexed as

COVID-19Quality of LifeDyspneaHospitalsHumansLungProspective StudiesSARS-CoV-2Tomography, X-Ray Computed

Identifiers

PMID33303540
PMCPMC7736755

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.